Urovant sciences ltd. (UROV)
Income statement / Yearly
Mar'19Mar'18
Operating expenses:
Research and development

92,198

32,359

General and administrative

18,585

4,640

Total operating expenses

110,783

36,999

Other income (expense):
Interest expense, net

-259

-

Other expense

257

38

Loss before provision for income taxes

-111,299

-37,037

Provision for income taxes

47

37

Net loss

-111,346

-37,074

Net loss per common share—basic and diluted

-4.43

-2.16

Weighted average common shares outstanding—basic and diluted

25,145

17,124